Skip to main content
. 2018 Jan 14;24:29–42.

Table 1. Variants that exhibit genome-wide significant and suggestive evidence of linkage to myopia from the collapsed haplotype pattern linkage analysis.

CHR HLOD ALPHA LOD POS GENE
10q26.13 3.73 1.00 3.73 146.7658 TACC2
10q26.2 2.77 1.00 2.77 156.932 DOCK1
15q13.3 2.64 0.87 2.42 27.82131 RYR3
9q31.3 2.58 1.00 2.58 117.7108 SVEP1
9q33.2 2.53 1.00 2.53 131.6962 CDK5RAP2
1p13.1 2.49 1.00 2.49 40.94913 IGSF21
10q25.3 2.41 1.00 2.41 133.0324 VWA2
10q24.31 2.34 1.00 2.34 119.6265 CWF19L1
10q26.11 2.15 1.00 2.15 141.0359 EIF3A
10q24.2 2.08 1.00 2.08 119.2729 ABCC2
15q15.2 2.04 1.00 2.04 42.58454 STARD9
12q24.13 2.03 1.00 2.03 129.8192 CCDC42B
1p31.3 1.98 1.00 1.98 94.08912 INADL
11q22.3 1.97 1.00 1.97 113.0644 EXPH5
12q23.2 1.94 1.00 1.94 117.4295 IGF1
12q24.13 1.94 1.00 1.94 129.8897 IQCD
6q15 1.92 1.00 1.92 99.52311 GABRR1

Table displaying the genome-wide significant and suggestive linkage signals from the collapsed haplotype pattern (CHP) variant two-point linkage analysis sorted by heterogeneity LOD (HLOD). CHP variants are multi-allelic pseudo-markers corresponding to a gene and created from SNPs with a MAF <0.15. The genome-wide significance threshold is 3.3 and the genome-wide suggestive threshold is 1.9, as recommended by Lander and Kruglyak. CHR=chromosomal region, HLOD=heterogeneity LOD score of the marker, ALPHA=estimated proportion of informative families showing evidence of linkage for each HLOD, LOD=cumulative LOD across all families, POS=position in cM of the gene, GENE=Gene location of the CHP marker.